A detailed history of Apg Asset Management N.V. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Apg Asset Management N.V. holds 7,755 shares of CRL stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,755
Previous 61,017 87.29%
Holding current value
$1.52 Million
Previous $12.6 Million 87.88%
% of portfolio
0.01%
Previous 0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$187.96 - $245.29 $10 Million - $13.1 Million
-53,262 Reduced 87.29%
7,755 $1.53 Million
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $1.29 Million - $1.68 Million
6,258 Added 11.43%
61,017 $12.6 Million
Q1 2024

May 14, 2024

BUY
$203.52 - $273.43 $3.31 Million - $4.45 Million
16,277 Added 42.3%
54,759 $14.8 Million
Q4 2023

Feb 13, 2024

SELL
$164.52 - $238.84 $448,481 - $651,077
-2,726 Reduced 6.62%
38,482 $9.1 Million
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $884,507 - $989,907
-4,549 Reduced 9.94%
41,208 $8.08 Million
Q2 2023

Aug 14, 2023

SELL
$183.71 - $210.25 $4,409 - $5,046
-24 Reduced 0.05%
45,757 $9.62 Million
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $1.46 Million - $1.97 Million
-7,592 Reduced 14.22%
45,781 $9.24 Million
Q4 2022

Feb 14, 2023

BUY
$197.11 - $250.07 $8.53 Million - $10.8 Million
43,282 Added 428.92%
53,373 $11.6 Million
Q3 2022

Nov 14, 2022

BUY
$182.44 - $250.54 $601,687 - $826,280
3,298 Added 48.55%
10,091 $2.03 Million
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $876,330 - $1.3 Million
4,293 Added 171.72%
6,793 $1.39 Million
Q1 2022

May 12, 2022

SELL
$255.51 - $362.11 $25,551 - $36,211
-100 Reduced 3.85%
2,500 $638,000
Q4 2021

Feb 11, 2022

SELL
$351.38 - $448.68 $456,794 - $583,284
-1,300 Reduced 33.33%
2,600 $861,000
Q3 2021

Nov 15, 2021

SELL
$372.64 - $458.3 $708,016 - $870,770
-1,900 Reduced 32.76%
3,900 $1.39 Million
Q2 2021

Aug 13, 2021

BUY
$294.17 - $371.65 $1.71 Million - $2.16 Million
5,800 New
5,800 $1.81 Million
Q3 2018

Nov 09, 2018

SELL
$112.11 - $134.54 $14.4 Million - $17.3 Million
-128,800 Closed
0 $0
Q2 2018

Aug 13, 2018

SELL
$102.37 - $117.25 $14.2 Million - $16.3 Million
-138,800 Reduced 51.87%
128,800 $12.4 Million
Q1 2018

May 14, 2018

SELL
$98.19 - $115.2 $9.94 Million - $11.7 Million
-101,200 Reduced 27.44%
267,600 $23.2 Million
Q4 2017

Jan 24, 2018

BUY
$100.43 - $118.09 $26.8 Million - $31.5 Million
266,700 Added 261.21%
368,800 $33.6 Million
Q3 2017

Oct 19, 2017

BUY
$96.72 - $109.26 $9.88 Million - $11.2 Million
102,100
102,100 $11 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.96B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Apg Asset Management N.V. Portfolio

Follow Apg Asset Management N.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.